![Jörn Drappa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörn Drappa
Hoofd Techniek/Wetenschap/O&O bij
ALUMIS INC.
Vermogen: 2 M $ op 31-07-2026
Profiel
Jörn Drappa was the founder of Viela Bio, Inc., founded in 2018, where the title held was Chief Medical Officer, Head-Research & Development from 2018 to 2021.
The current job is Chief Medical Officer at Alumis, Inc. starting in 2022.
Former jobs include Associate Director-Medical at Amgen, Inc. from 2003 to 2006; Senior Medical Director at Genentech, Inc. from 2008 to 2011; Vice President-Clinical Development at MedImmune LLC from 2011 to 2018; Executive Vice President-Research & Development at Horizon Therapeutics Ltd. (Ireland) in 2021; Chief Medical Officer at Ventyx Biosciences, Inc. from 2021 to 2022; and Director at Alpine Immune Sciences, Inc. from 2022 to 2024.
Education includes a doctorate from Universität zu Köln conferred in 1991 and a doctorate from Weill Cornell Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALUMIS INC. 0,05% | 03-08-2026 | 56.892 ( 0,05% ) | 2 M $ | 31-07-2026 |
Actieve functies van Jörn Drappa
| Bedrijven | Functie | Begin |
|---|---|---|
| ALUMIS INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2022 |
Eerdere bekende functies van Jörn Drappa
| Bedrijven | Functie | Einde |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur/Bestuurslid | 20-05-2024 |
| VENTYX BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 05-05-2022 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
| VIELA BIO, INC. | Oprichter | 15-03-2021 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Hoofd Techniek/Wetenschap/O&O | 01-02-2018 |
Opleiding van Jörn Drappa
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
69
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
